1Siegel RR, Luke RG, Hellebusch AA. Reduction of toxicity of corticosteroid therapy after renal transplantation. Am J Med, 1972, 53 : 159 - 169.
2Chan L, French ME, Beare J, et al. Prospective trial of high-dose versus low-dose prednisolone in renal transplant patients. Transplant Proc, 1980, 12:323 -326.
3Buckels JA, Mackintosh P, Barnes AD. Controlled trial of low versus high dose oral steroid therapy in 100 cadaveric renal transplants. Proc Eur Dial Transplant Assoc, 1981, 18:394-399.
4Park GD, Bartucci M, Smith MC. High-versus low-dose methylprednisolone for acute rejection episodes in renal transplantation. Nephron, 1984, 36: 80-83.
5Hricik DE, Almawi WY, Strom TB. Trends in the use of glucocorticolds in renal transplantation. Transplantation, 1994, 57: 979-989.
6Sinclair NR. Canadian muhicenter transplant study group: Low dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. CMAJ, 1992, 147:645-657.
7Vincenti F, Monaco A, Grinyo J, et al. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. Am J Transplant, 2003, 3:306-311.
8Matas AJ, Rameharan T, Paraskevas S, et al. Rapid discontinuation of steroids in living donor kidney transplantation: A pilot study. Am J Transplant, 2001, 1 : 278 -283.
9Matas A J, Kandaswamy R, Gillingham KJ, et al. Prednisone-free maintenance immunosuppression: A 5-year experience. Am J Transplant, 2005, 5 : 2473 - 2478.
10Birkeland SA. Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate maintenance therapy. Transplantation, 1998, 66:1207 -1210.
3Smith JM, Ho PL, McDonald RA. Transplantation out-come in adolescents:a report of the North American Pediatric Renal Transplant Cooperative Study ( NAPRTCS ). Pediatr Transplant, 2002, 6(6):493-499.
